Guangying Cui

5.5k total citations · 2 hit papers
82 papers, 3.4k citations indexed

About

Guangying Cui is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Guangying Cui has authored 82 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 20 papers in Cancer Research and 17 papers in Epidemiology. Recurrent topics in Guangying Cui's work include RNA modifications and cancer (18 papers), Gut microbiota and health (16 papers) and Cancer-related gene regulation (10 papers). Guangying Cui is often cited by papers focused on RNA modifications and cancer (18 papers), Gut microbiota and health (16 papers) and Cancer-related gene regulation (10 papers). Guangying Cui collaborates with scholars based in China, United States and Japan. Guangying Cui's co-authors include Zhigang Ren, Ranran Sun, Zujiang Yu, Ang Li, Xiaolong Chen, Benchen Rao, Lanjuan Li, Hongyan Diao, Jianhao Li and Yan Yu and has published in prestigious journals such as Advanced Materials, PLoS ONE and Gut.

In The Last Decade

Guangying Cui

81 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma

2018 543 citations Zhigang Ren, Ang Li et al. Gut profile →
A Metal–Polyphenol‐Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy

2019 387 citations Zhigang Ren, Ranran Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guangying Cui China	33	2.1k	729	588	576	381	82	3.4k
Zujiang Yu China	26	1.7k 0.8×	628 0.9×	420 0.7×	573 1.0×	408 1.1×	101	3.0k
Suradej Hongeng Thailand	35	1.6k 0.8×	350 0.5×	810 1.4×	352 0.6×	224 0.6×	318	4.7k
Fangfang Guo China	25	1.6k 0.8×	373 0.5×	623 1.1×	386 0.7×	634 1.7×	58	3.2k
Yufeng Wang China	35	1.9k 0.9×	814 1.1×	889 1.5×	598 1.0×	157 0.4×	223	4.3k
Mengxia Li China	31	1.7k 0.8×	449 0.6×	516 0.9×	374 0.6×	198 0.5×	191	3.4k
Feng Xu China	30	1.1k 0.5×	401 0.6×	313 0.5×	464 0.8×	488 1.3×	130	3.6k
Han Zhang China	32	1.3k 0.6×	377 0.5×	1.2k 2.0×	485 0.8×	306 0.8×	235	3.7k
Yang Xia China	38	2.1k 1.0×	952 1.3×	841 1.4×	455 0.8×	270 0.7×	195	4.5k
Guanmin Jiang China	28	2.4k 1.2×	1.3k 1.7×	717 1.2×	693 1.2×	294 0.8×	54	4.7k
Roni Nowarski Israel	14	2.1k 1.0×	405 0.6×	899 1.5×	386 0.7×	383 1.0×	17	3.7k

Countries citing papers authored by Guangying Cui

Since Specialization

Citations

This map shows the geographic impact of Guangying Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangying Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangying Cui more than expected).

Fields of papers citing papers by Guangying Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangying Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangying Cui. The network helps show where Guangying Cui may publish in the future.

Co-authorship network of co-authors of Guangying Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Guangying Cui. A scholar is included among the top collaborators of Guangying Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangying Cui. Guangying Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Guangying, et al.. (2024). The feasibility and accuracy of the method for selecting the optimal size of double-lumen tube in thoracic surgery: a prospective, randomized controlled trial. Scientific Reports. 14(1). 17539–17539. 1 indexed citations

Dong, Zihui, et al.. (2023). Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma. Frontiers in Pharmacology. 14. 1172908–1172908. 7 indexed citations

Zhang, Guizhen, Liwen Liu, Jianhao Li, et al.. (2023). NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer. Cell Death Discovery. 9(1). 219–219. 37 indexed citations

Wang, Huifen, et al.. (2022). Metagenomic next-generation sequencing assists in the diagnosis of Cryptococcus pneumonia: Case series and literature review. Frontiers in Public Health. 10. 971511–971511. 4 indexed citations

Yu, Bo, Benchen Rao, Ying Sun, et al.. (2022). The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment. Frontiers in Immunology. 13. 1051987–1051987. 33 indexed citations

Cui, Guangying, Benchen Rao, Zhaohai Zeng, et al.. (2022). Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up. Military Medical Research. 9(1). 32–32. 32 indexed citations

Gao, Ming, Haiyu Wang, Hong Luo, et al.. (2021). Characterization of the Human Oropharyngeal Microbiomes in SARS‐CoV‐2 Infection and Recovery Patients. Advanced Science. 8(20). e2102785–e2102785. 36 indexed citations

Rao, Benchen, Jiamin Lou, Weijie Wang, et al.. (2020). Human microbiome is a diagnostic biomarker in hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 19(2). 109–115. 26 indexed citations

Wang, Haiyu, Benchen Rao, Jiamin Lou, et al.. (2020). The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 8. 55–55. 124 indexed citations

10.

Cui, Xichun, Zhifang Wang, Liwen Liu, et al.. (2019). The Long Non-coding RNA ZFAS1 Sponges miR-193a-3p to Modulate Hepatoblastoma Growth by Targeting RALY via HGF/c-Met Pathway. Frontiers in Cell and Developmental Biology. 7. 271–271. 24 indexed citations

11.

Ren, Zhigang, Xinmei Chen, Liangjie Hong, et al.. (2019). Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis. Small. 16(2). e1905233–e1905233. 100 indexed citations

12.

He, Yuting, Chen Xue, Yan Yu, et al.. (2018). CD44 is overexpressed and correlated with tumor progression in gallbladder cancer. Cancer Management and Research. Volume 10. 3857–3865. 45 indexed citations

13.

Ren, Zhigang, Ang Li, Jianwen Jiang, et al.. (2018). Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 68(6). 1014–1023. 543 indexed citations breakdown →

14.

Bao, Jie, Yan Yu, Jianan Chen, et al.. (2018). MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway. Cell Death and Disease. 9(10). 1045–1045. 72 indexed citations

15.

Zhu, Weiwei, Hongqiang Li, Yu Yan, et al.. (2018). Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients. Cancer Management and Research. Volume 10. 5735–5745. 36 indexed citations

16.

Hou, Xianliang, Chong Lu, Sisi Chen, et al.. (2016). High Throughput Sequencing of T Cell Antigen Receptors Reveals a Conserved TCR Repertoire. Medicine. 95(10). e2839–e2839. 21 indexed citations

17.

Hou, Xianliang, Mingbang Wang, Chong Lu, et al.. (2016). Analysis of the Repertoire Features of TCR Beta Chain CDR3 in Human by High-Throughput Sequencing. Cellular Physiology and Biochemistry. 39(2). 651–667. 33 indexed citations

18.

Zhu, Yunan, Hongyu Jia, Jianing Chen, et al.. (2015). Decreased Osteopontin Expression as a Reliable Prognostic Indicator of Improvement in Pulmonary Tuberculosis: Impact of the Level of Interferon-γ-Inducible Protein 10. Cellular Physiology and Biochemistry. 37(5). 1983–1996. 13 indexed citations

19.

Diao, Hongyan, Guangying Cui, Jianing Chen, et al.. (2015). Osteopontin promotes dendritic cell maturation and function in response to HBV antigens. Drug Design Development and Therapy. 9. 3003–3003. 20 indexed citations

20.

Diao, Hongyan, Jianqin He, Jianing Chen, et al.. (2014). A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment. Immunology Letters. 160(1). 65–71. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact